University of Alberta

99 articles about University of Alberta

• Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology

  6/8/2022

  Tonix Pharmaceuticals Holding Corp. announced that Tom Hobman, Ph.D., Professor, Department of Cell Biology, University of Alberta, presented data from his laboratory at The University of Alberta as a keynote presentation at the 4th Symposium of the Canadian Society for Virology held in Edmonton, Alberta, Canada on June 5, 2022.

• 

  Cash-Rich CRISPR Therapeutics Expects Year Filled with Milestones

  5/10/2022

  CRISPR Therapeutics reported in its first-quarter financials, as of March 31, it had $2.221 billion in cash, cash equivalents and marketable securities to drive its progress.

• The Diabetes Research Institute Foundation Joins Forces with Their Canadian Counterpart to Form Powerhouse Partnership to Fund the Search for a Diabetes Cure

  5/9/2022

  The Diabetes Research Institute along with the Diabetes Research Institute Foundation Canada and Alberta Diabetes Institute at the University of Alberta, Canada's largest stand-alone research facility dedicated to finding a cure of diabetes, announced the launch of a research partnership to advance efforts to find a cure for diabetes.

• 

  Research Roundup: Mount Sinai Uncovers a Key to Breast Cancer Metastasis

  4/29/2022

  Mount Sinai researchers have discovered a key mechanism for how this occurs in breast cancer. For that and more research stories, continue reading.

• Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 and TNX-1830, for the Prevention of COVID-19

  5/7/2020

  TNX-1810, TNX-1820 and TNX-1830 are Designed to Express Protein Antigens from SARS-CoV-2 That are Different from TNX-1800, Which is Designed to Express Spike Protein

• ACAMP Working with University of Alberta has Developed a Washable Cloth Based Filter and Plastic Respirator With Over 95% Filtration Efficiency

  4/28/2020

  PPE A95 Canadian respirator to help prevent the spread of COVID-19

• Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids

  12/17/2019

  Successful impregnation of gum arabic-CoQ10 bolsters Ceapro’s efforts to develop innovative delivery systems composed of new chemical complexes

• 

  New Research Could Help Personalize Treatment for Myasthenia Gravis

  8/30/2019

  Researchers with the University of Alberta recently identified a unique biological marker for myasthenia gravis that might be used for a diagnostic test and to predict the course of the disease. It may also have implications for defining more personalized treatments.
• 

  September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...

  9/21/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

• IBM And University of Alberta Publish New Data On Machine Learning Algorithms To Help Predict Schizophrenia

  7/21/2017

• DNA Motors In Living Cells Start With Microrna Keys, University of Alberta Study Reveals

  3/8/2017

• Salt Can Make Surgical Masks Into A Virus Killer, University of Alberta Study

  1/10/2017

• New Blood Test Identifies Women At Risk Of Preterm Delivery As Early As 17 Weeks Of Pregnancy, University of Alberta Study

  8/9/2016

• RespireRx , University of Alberta And University of Florida Provide Update On Collaborative Research Activities

  4/1/2016

• Seismic For The Spine: Vibration Technology Offers Alternative To MRI, University of Alberta Study

  3/11/2016

• Zika Virus Researchers Join Forces To Develop Handheld Detection Device, University of Alberta Study

  2/19/2016

• ProtoKinetix Inc. Begins Testing Diabetic Mice With AAGP At University of Alberta

  9/18/2015

• ProtoKinetix Inc. Reports On Its Strong Collaboration With The James Shapiro Laboratory At The University of Alberta

  8/4/2015

• ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Second Clinical Trial Site At University of Alberta

  7/30/2015

• NightstaRx And University of Alberta Announce The Start Of The First Canadian Gene Therapy Study To Treat Choroideremia

  6/29/2015